273 related articles for article (PubMed ID: 2464333)
21. Induction of CIITA and modification of in vivo HLA-DR promoter occupancy in normal thymic epithelial cells treated with IFN-gamma: similarities and distinctions with respect to HLA-DR-constitutive B cells.
Rigaud G; De Lerma Barbaro A; Nicolis M; Cestari T; Ramarli D; Riviera AP; Accolla RS
J Immunol; 1996 Jun; 156(11):4254-8. PubMed ID: 8666795
[TBL] [Abstract][Full Text] [Related]
22. Modulation by interferons of HLA antigen, high-molecular-weight melanoma associated antigen, and intercellular adhesion molecule 1 expression by cultured melanoma cells with different metastatic potential.
Maio M; Gulwani B; Langer JA; Kerbel RS; Duigou GJ; Fisher PB; Ferrone S
Cancer Res; 1989 Jun; 49(11):2980-7. PubMed ID: 2497970
[TBL] [Abstract][Full Text] [Related]
23. HLA-DR synthesis induction and expression in HLA-DR-negative carcinoma cell lines of diverse origins by interferon-gamma but not by interferon-beta.
Shaw AR; Chan JK; Reid S; Seehafer J
J Natl Cancer Inst; 1985 Jun; 74(6):1261-8. PubMed ID: 3923246
[TBL] [Abstract][Full Text] [Related]
24. Regulation of MHC class II expression in glioma cells by class II transactivator (CIITA).
Takamura Y; Ikeda H; Kanaseki T; Toyota M; Tokino T; Imai K; Houkin K; Sato N
Glia; 2004 Mar; 45(4):392-405. PubMed ID: 14966870
[TBL] [Abstract][Full Text] [Related]
25. Control of MHC class II gene expression in autoimmune, infectious, and neoplastic diseases.
Guardiola J; Maffei A
Crit Rev Immunol; 1993; 13(3-4):247-68. PubMed ID: 8110378
[TBL] [Abstract][Full Text] [Related]
26. Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.
Rodríguez T; Méndez R; Del Campo A; Jiménez P; Aptsiauri N; Garrido F; Ruiz-Cabello F
BMC Cancer; 2007 Feb; 7():34. PubMed ID: 17319941
[TBL] [Abstract][Full Text] [Related]
27. Transcriptional induction of H2 (class I) antigens and beta 2 microglobulin by interferon-gamma in interferon-sensitive and interferon-resistant Friend leukemia cells.
Coccia E; Marziali G; Fiorucci G; Romeo G; Affabris E; Battistini A; Rossi GB
J Biol Regul Homeost Agents; 1992; 6(1):21-5. PubMed ID: 1442172
[TBL] [Abstract][Full Text] [Related]
28. IFN regulatory factor-1 plays a central role in the regulation of the expression of class I and II MHC genes in vivo.
Hobart M; Ramassar V; Goes N; Urmson J; Halloran PF
J Immunol; 1997 May; 158(9):4260-9. PubMed ID: 9126988
[TBL] [Abstract][Full Text] [Related]
29. Regulation of TL antigen expression. Analysis of the T18d promoter region and responses to IFN-gamma.
Wang IM; Mehta V; Cook RG
J Immunol; 1993 Sep; 151(5):2646-57. PubMed ID: 8360484
[TBL] [Abstract][Full Text] [Related]
30. Constitutive and IFNgamma-induced activation of MHC2TA promoter type III in human melanoma cell lines is governed by separate regulatory elements within the PIII upstream regulatory region.
van der Stoep N; Quinten E; Alblas G; Plancke A; van Eggermond MC; Holling TM; van den Elsen PJ
Mol Immunol; 2007 Mar; 44(8):2036-46. PubMed ID: 17067677
[TBL] [Abstract][Full Text] [Related]
31. Modulation of major histocompatibility complex class 1 genes in human retinoblastoma cells by interferons.
Barez S; Boumpas DT; Percopo CM; Anastassiou ED; Hooks JJ; Detrick B
Invest Ophthalmol Vis Sci; 1993 Aug; 34(9):2613-21. PubMed ID: 7688356
[TBL] [Abstract][Full Text] [Related]
32. Loss of interferon-gamma inducibility of the MHC class II antigen processing pathway in head and neck cancer: evidence for post-transcriptional as well as epigenetic regulation.
Meissner M; Whiteside TL; van Kuik-Romein P; Valesky EM; van den Elsen PJ; Kaufmann R; Seliger B
Br J Dermatol; 2008 May; 158(5):930-40. PubMed ID: 18284388
[TBL] [Abstract][Full Text] [Related]
33. Novel regulation of an MHC class I gene response to interferon-gamma.
Schwarz DA; Buhlmann JE; Kuhne MR; Lam TM; White HD; Green WR
Cell Immunol; 1993 Aug; 150(1):90-100. PubMed ID: 7688271
[TBL] [Abstract][Full Text] [Related]
34. IFN gamma/TNF alpha synergism in MHC class II induction: effect of nicotinamide on MHC class II expression but not on islet-cell apoptosis.
Kim KA; Kim S; Chang I; Kim GS; Min YK; Lee MK; Kim KW; Lee MS
Diabetologia; 2002 Mar; 45(3):385-93. PubMed ID: 11914744
[TBL] [Abstract][Full Text] [Related]
35. pRB is required for interferon-gamma-induction of the MHC class II abeta gene.
Zhu X; Pattenden S; Bremner R
Oncogene; 1999 Sep; 18(35):4940-7. PubMed ID: 10490828
[TBL] [Abstract][Full Text] [Related]
36. Interferons.
Morris AG
Immunol Suppl; 1988; 1():43-5. PubMed ID: 2454889
[TBL] [Abstract][Full Text] [Related]
37. Differential regulation of HLA-A3 and HLA-B7 MHC class I genes by IFN is due to two nucleotide differences in their IFN response sequences.
Hakem R; Le Bouteiller P; Jezo-Bremond A; Harper K; Campese D; Lemonnier FA
J Immunol; 1991 Oct; 147(7):2384-90. PubMed ID: 1717558
[TBL] [Abstract][Full Text] [Related]
38. MHC class I surface expression in embryo-derived cell lines inducible with peptide or interferon.
Bikoff EK; Jaffe L; Ribaudo RK; Otten GR; Germain RN; Robertson EJ
Nature; 1991 Nov; 354(6350):235-8. PubMed ID: 1720508
[TBL] [Abstract][Full Text] [Related]
39. Differential expression and interferon response of HLA class I genes in thymocyte lines and response variants.
Girdlestone J; Milstein C
Eur J Immunol; 1988 Jan; 18(1):139-43. PubMed ID: 2450029
[TBL] [Abstract][Full Text] [Related]
40. Independent evolution of antiviral and growth-modulating activities of interferon.
Carter WA; Swartz H; Gillespie DH
J Biol Response Mod; 1985 Oct; 4(5):447-59. PubMed ID: 2416881
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
